In this series of low stage HGS ovarian carcinomas, we observed four TP53 mutations (R273C, R248W, R248Q and R175H) that were previously described as ‘neomorphic’ (gain of function, GOF) changes (39). The gene discussed is TP53; the disease is ovarian carcinoma.